Background: GDF11 modulates embryonic patterning and kidney organogenesis. Herein, we sought to define GDF11 function in the adult kidney and in renal diseases. Methods: In vitro renal cell lines, genetic, and murine in vivo renal injury models were examined. Results: Among tissues tested, Gdf11 was highest in normal adult mouse kidney. Expression was increased acutely after 5/6 nephrectomy, ischemia-reperfusion injury, kanamycin toxicity, or unilateral ureteric obstruction. Systemic, high-dose GDF11 administration in adult mice led to renal failure, with accompanying kidney atrophy, interstitial fibrosis, epithelial-to-mesenchymal transition of renal tubular cells, and eventually death. These effects were associated with phosphorylation of SMAD2 and could be blocked by follistatin. In contrast, Gdf11 heterozygous mice showed reduced renal Gdf11 expression, renal fibrosis, and expression of fibrosis-associated genes both at baseline and after unilateral ureteric obstruction compared with wild-type littermates. The kidney-specific consequences of GDF11 dose modulation are direct effects on kidney cells. GDF11 induced proliferation and activation of NRK49f renal fibroblasts and also promoted epithelial-to-mesenchymal transition of IMCD-3 tubular epithelial cells in a SMAD3-dependent manner. Conclusion: Taken together, these data suggest that GDF11 and its downstream signals are critical in vivo mediators of renal injury. These effects are through direct actions of GDF11 on renal tubular cells and fibroblasts. Thus, regulation of GDF11 presents a therapeutic target for diseases involving renal fibrosis and impaired tubular function.
Introduction
The transforming growth factor-β (TGF-β) super family and its signaling pathways have been implicated in many aspects The TFG-β family member, growth differentiation factor-11 (GDF-11/GDF11, also known as BMP-11), remains misunderstood. [20] [21] [22] [23] [24] [25] Essential roles for this protein in embryonic patterning and development, 20 , 26-28 as well as kidney organogenesis, 20, 29 have been demonstrated using targeted deletion of Gdf11 . Indeed, the majority of Gdf11 null mice exhibit bilateral kidney agenesis. 29 GDF11's functions in the adult animal are highly controversial. 30 Recent studies report that circulating GDF11 declines as one ages and that GDF11 supplementation reverts the aging phenotype in heart, muscle, and brain in mice. [31] [32] [33] [34] Using similar approaches, other labs report null or opposite results, provoking fierce debate. 30 , 35-41 Given these conflicting studies, currently both the essential, nonredundant roles of GDF11 in the adult and the consequences of sustained administration are unknown.
GDF11 exerts its developmental effects at least in part by binding TGF-β/activin receptors type I (TGFBR1/ALK5) 42 and type II (ACVR2A, ACVR2B). 43 Receptor binding stimulates intrinsic serinethreonine kinase activity and induces phosphorylation and nuclear translocation of SMAD proteins, downstream transcription factors. 44, 45 Because of its essential role in kidney development and the reported roles of ALK5, ACVR, and SMAD in kidney disease, GDF11 was also hypothesized to play an important role in adult kidney. Herein, we show essential nonredundant roles for GDF11 in mediating kidney injury and fibrosis, along with detrimental effects of exogenous GDF11 on renal function. Studies in cell culture suggest these effects are direct actions of GDF11 on renal fibroblasts and tubular epithelial cells.
Materials and Methods

Materials
Diuresis and urine collection were performed in Nalgene metabolic cages (Nalge Nunc, Rochester, NY). Antibodies used were α-SMA, vimentin, E-cadherin (Sigma, St. Louis, MO), SMAD2, pS-MAD2 (Cell Signaling Technology, Beverly, MA), PCNA (Santa Cruz Biotechnology, Santa Cruz, CA), collagen type I, collagen type IV (Biodesign International, Saco, ME), and Alexa Fluor 488 (Molecular Probes, Eugene, OR). Western blotting was done using HRPconjugated secondary antibodies and SuperSignal West Pico or Femto (Pierce, Rockford, IL). Immunohistochemical staining was done using Vectastain (Vector Laboratories, Burlingame, CA) and DakoCytomation kits (DAKO, Carpinteria, CA). DNA was purified with Puregene Genomic DNA Purification Kit (Gentra Systems, Minneapolis, MN). Primers were obtained from Sigma Genosys.
Mice
Athymic nu/nu mice were purchased from Harlan (Indianapolis, IN). Male C57BL6/J used in 5/6 nephrectomy experiments were originally obtained from The Jackson Laboratory (Bar Harbor, ME). Male C57BL6/J mice (8-10 weeks of age) were used for characterization of Gdf11 expression after kidney injury. Female athymic nu/nu mice were used for cell injections. C57:Gdf11 tm1Lee mice were generated by crossing Gdf11 + / − females to C57BL/6J males. Genotyping was by polymerase chain reaction (PCR) on tail deoxyribonucleic acid (DNA) as described. 29 All experiments were performed according to the guidelines of the Institutional Animal Care and Use Committees at the University of Miami or Indiana University School of Medicine, Indianapolis. Mice were housed in a temperature-controlled, 12-hour light/dark photocycle and maintained on a standard rodent diet with free water and food access. Surgical procedures were performed on 8-12-week-old male mice under isoflurane general anesthesia, using a nonrebreathing apparatus on a heated recirculating waterbed. Buprenorphine (0.05 mg/kg) was given by intramuscular injection once daily for 3 days after surgery for pain control. Unilateral ureteric obstruction was performed by midline incision and gentle manipulation of the abdominal contents to reveal the right ureter, which was then tied twice with sutures. Subtotal nephrectomy was performed by ligation and removal of one kidney and resection of two-thirds of the remaining kidney on the same day. Kanamycin (360 g/kg) was delivered in a single intraperitoneal (ip) injection.
For GDF11 administration, a Chinese hamster ovary (CHO) cell line stably producing GDF11 (CHO-GDF11) was obtained by introduction of the plasmid vector pMSXND, containing full-length Gdf11 cDNA into DHFR-deficient CHO-DUXX cells by protoplast fusion and subsequent methotrexate selection. A similarly selected CHO cell line (CHO-control) not expressing detectable recombinant protein was used as a control. Female athymic nude mice (6-8 weeks of age) were intramuscularly (im) injected in the upper rear leg with either CHO-GDF11 cells or CHO-control cells in 0.1 mL PBS. For delivery of recombinant GDF11 (R&D Systems, Minneapolis, MN), C57BL/6J male mice (8 weeks of age) were implanted with 7-day Alzet osmotic pumps in the peritoneum. Controls received pumps filled with saline. For all experiments, blood and tissue were collected under general anesthesia at time they were killed. Water content of carcasses and kidneys was determined by calculating the difference in mass before and after oven drying. All in vivo studies with cell lines were repeated > 4 times with at least 8 mice per group.
Serum and urine chemistry
Urine osmolalities were measured using a freezing-point depression osmometer using a modified Jaffe method. Total protein in urine was measured using the Coomassie Plus Bradford Assay (Pierce, Rockford, IL). Blood urea nitrogen (BUN), creatinine, sodium, potassium, and phosphorus levels in serum were measured on an autoanalyzer. Creatinine clearance was calculated using 24-hour samples.
Histology and morphometry
Formalin-fixed, paraffin-embedded kidneys were cut into 5-μm sections onto glass slides and stained with hematoxylin and eosin, periodic acid-Schiff, immunohistochemistry, Masson's Trichrome, or Sirius Red. Quantification of collagen was performed using Photoshop CS (Adobe, San Jose, CA) to color threshold with ImageJ (NIH, Bethesda, MD). Each measurement was from 10 randomly chosen, nonoverlapping 400 × fields per treatment group ( n = 4). For morphometry, the surface area of 40 glomeruli and 80 tubules per mouse were measured on periodic acid-Schiff-stained kidney sections at day 12, using an Olympus BH-2 microscope (Shinjuku, Tokyo), a Micro Image A209RGB color video camera, and MetaMorph 4.5 (Universal Imaging Co., West Chester, PA). Because subcapsular and juxtamedullary glomeruli differ in size, glomeruli were randomly selected in each section as they were encountered between the capsule and the juxtamedullary region. The same approach was used to select transverse sections of the tubules. In situ hybridization for Gdf11 was done essentially as described, 46 using digoxigenin-labeled riboprobes on frozen sections. The riboprobes used for the Gdf11 transcript corresponded only to the proregion and the 3 UTR to avoid cross-hybridization to myostatin.
Western blotting analysis
Individual kidney samples were homogenized in radioimmunoprecipitation assay buffer and centrifuged. Protein concentrations were determined using the Coomassie Plus Bradford Assay Kit 
(Pierce). Total kidney protein content was calculated using starting kidney weight multiplied by measured milligrams of protein per gram of kidney weight. Blots of at least 4 individual mice per group and time point were performed. For blots presented, equivalent amounts of protein from individual kidney samples were pooled at each time point, each representing 3-4 individual kidneys. Samples were suspended in Laemmli loading buffer and boiled for 5 minutes, then subjected to sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) on 10.5%-14% gradient gels. Chemiluminescent signals were detected by exposure to Kodak BioMax Light film (Rochester, NY). Bands were analyzed by densitometry using ImageJ 1.30 software. Ponceau-S staining was used as a loading control.
Northern blot and qRT-PCR (Reverse transcription polymerase chain reaction)
Total ribonucleic acid (RNA) was extracted from TRIzol (Fischer Scientific). Northern blot of total or twice poly(A) + -selected RNA was performed as described. 47 Primer 3 was used on the Gdf11 mRNA sequence XM-125935 to design the optimal intronspanning primer pair, 5'-AGGACTTCTTGGAAGAGGACGAG-3' and 5'-CCTTGGGGCTGAAGTGGAAA-3', for an amplicon of 129 bp. Other primer pairs used are described in Table 1 . Reverse transcription was performed using random primers on 1.25 μg total RNA, using a High-Capacity cDNA Archive Kit (Applied Biosystems-Life Technologies, Carlsbad, CA). PCRs were performed using the TaqMan Universal Master Mix (Applied Biosystems-Life Technologies) or the iQ SybrGreen Supermix (BioRad Laboratories, Hercules, CA) per manufacturer's instructions. The amplification program consisted of 1 cycle at 95 °C for 10 minutes (hot start), followed by 40 cycles of 95 °C for 15 seconds and 65 °C for 1 minutes. PCR products were analyzed on ethidium bromide-stained 2% agarose gels to verify the specificity of PCR amplification, and melting curves and standard curves were obtained for each primer pair on normal kidney cDNA. Six replicates were performed for each experimental sample. Each sample was normalized to 18S rRna or Gapdh transcripts. Relative changes in gene expression were quantified using the 2 − CT method. 48 
Cell culture
NRK49f, NRK52e, HK-2, and IMCD-3 cell lines were purchased from ATCC (Mannassas, VA). For proliferation studies, NRK49f cells were seeded in 96-well plates in media containing recombinant GDF11 or TGF-β (R & D Systems) and incubated for 5 days. An MTT assay was used to measure cell viability. For bright-field morphological analysis and preparation of Western blot and PCR extracts, cells were grown in plastic dishes. For αSMA immunohistochemistry and immunofluorescence of SMAD2, E-cadherin, vimentin, and αSMA cells were grown in chamber slides (Nalge Nunc). For immunofluorescence, cells were visualized on a Zeiss LSM510/UV confocal microscope. Inhibitors were added simultaneously with 50 ng/mL GDF11 as follows: 50 ng/mL follistatin (R&D Systems), 500 ng/mL SB-431542 (Sigma), and 10 μM SIS3 (Calbiochem-EMD Millipore, Darmstadt, Germany).
Statistical analysis
All in vivo results shown are representative of experiments performed at least thrice. In vitro data were performed at least twice. All data are presented as mean ± standard error of the mean. Data were analyzed for significance using unpaired two-tailed Student t test or one-way analysis of variance with Tukey-Kramer multiple comparisons post-test for groups larger than two. P < .05 was considered significant.
Results
GDF11 expression is increased in adult mouse kidney after acute kidney injury
Northern blot analysis detected two GDF11 mRNA transcripts ( ∼4.2 kb and 3.2 kb) in multiple adult mouse tissues, although expression was most prominent in the kidney and brain ( Fig. 1 , A ) . In situ hybridization for GDF11 expression in the post-natal kidney was difficult due to low signal; nonetheless, it demonstrated staining in distal tubules, cortical collecting ducts, and medullary rays ( Fig. 1 , B ) . We then examined GDF11 in commonly used mouse models of acute kidney injury (AKI). First, 5/6 nephrectomy * P < .05, * * P < .01, * * * P < .001.
Fig. 2.
GDF11 administration induces renal failure. Blood urea nitrogen (BUN), serum creatinine, and phosphorus, along with creatinine clearance in control ( white bars ) and GDF11-treated ( black bars ) mice killed on the indicated day after injection ( n = 4-12 mice each). * P < .05 , * * * P < .001.
(5/6Nx, removal of one kidney in total and 2/3 of the other) induces AKI within 10-12 days after injury, followed by modest compensatory hypertrophy affecting most components of the residual nephrons. [49] [50] [51] Northern blot analysis of mRNA from remnant kidneys after 5/6Nx revealed increased Gdf11 expression as early as 6-12 hours ( Fig. 1 , C ) . Second, kanamycin intoxication was used to induce extended cortical necrosis and acute tubular necrosis, which is typically followed by compensation, tissue repair, and regeneration. Indeed, Gdf11 expression was increased in the kidneys of mice treated with a single dose of kanamycin ( Fig. 1 , C ) , demonstrating similar timing as for the subtotal nephrectomy ( Fig. 1 , D ) .
Third, unilateral ureteric obstruction (UUO) is a model of progressive obstructive nephropathy, marked by profound cortical ballooning and fibrosis. Quantitative rtPCR (qPCR) demonstrated a 3-6-fold induction of Gdf11 ( Fig. 1 , E ) in the obstructed kidney after UUO. These results suggest that kidney injury of various etiologies leads to increased GDF11.
Exogenous GDF11 administration induces kidney injury and urine-concentrating defects
To study whether GDF11 increases in kidney injury might be pathogenic or compensatory in response to injury, we delivered GDF11 by injecting CHO cells expressing recombinant GDF11 (CHO- [52] [53] [54] [55] [56] [57] [58] [59] [60] including the closely related myostatin. GDF11-treated mice gradually lost weight and by 12 days exhibited a hunched posture and lethargy consistent with uremia. GDF11-treated mice developed severe acute kidney injury with elevated BUN, creatinine, phosphorus, and reduced creatinine clearance ( Fig. 2 and Table 2 ). These mice had polyuria and low urine osmolarity despite similar serum sodium and osmolarity, indicative of a urinary concentrating defect ( Table 2 ). The decreased kidney function (increased BUN and creatinine) in GDF11-treated mice did not reflect volume depletion because of the polyuria, as GDF11-treated mice had an appropriate increase in water intake. Moreover, GDF-11-treated and control mice had statistically indistinguishable total body water content (GDF11: 45.7% ± 2.3% versus control: 40.35% ± 4.3%, n = 3 per group, p = .13). Weight loss, kidney dysfunction, and death were specific to GDF-11 expression because these effects were not observed in CHO-control mice ( Fig. 2 , A -D and Table 2 ) or in mice injected with other CHO cell lines expressing recombinant proteins including GDF-1, GDF-2, GDF-10, follistatin, IL-6, or myostatin propeptide ( not presented ). Similar, although less-dramatic results were observed using recombinant GDF11 delivered to C57BL/6 male mice via osmotic minipumps. GDF11 (10 μg over 7 days) induced a rise in BUN over carrier-treated mice (GDF11: 41.25 ± 3.326 versus carrier: 26.50 ± 2.958; n = 4 per group, P < .02) and weight loss of 7.89% ± 2.76% ( P < .05) versus carrier controls, suggesting effects in the CHO-GDF11 mice were because of GDF11 and not other properties of the cells.
Exogenous GDF11-induced kidney injury with protein loss, tubular proliferation, and fibrosis
At necropsy, kidney mass from CHO-GDF11 mice was significantly reduced compared with controls. In a time-course analysis, more prolonged GDF11 treatment led to progressive declines of kidney mass and reduced total kidney protein ( Fig. 3 , A , B ) . However total kidney water and mRNA content were unchanged while DNA content was increased ( Fig. 3 , C ) . Histology showed the primary abnormality in GDF11-treated mice was atrophy of the tubular epithelial cells, which demonstrated relatively scant cytoplasm ( Fig. 3 , D ) . Overall, kidneys from GDF11-treated mice showed medullary atrophy and cortical thinning with a reduction in tubule area, although glomerular area was unchanged ( Fig. 3 , E ) .
Reduced kidney mass was apparently because of loss of protein and not cell death. No evidence indicated tubular cell apoptosis histologically ( Fig. 3 , D ) or by caspase-3 activity or caspase-3 cleavage by Western blotting (data not presented). There was, however, evidence of cell proliferation. Proliferating cell nuclear antigen (PCNA)-positive cells along with mitotic figures were observed in the interstitium, glomeruli, and tubular epithelium, indicating that GDF11-induced cellular proliferation ( Fig. 3 , F ) , with the majority of labeled cells being tubular epithelial cells. This was not a late effect of GDF11, given that PCNA levels were increased in total kidney extract as early as 3d after onset of treatment ( Fig. 3 , F ) . Consistent with cell proliferation induced by GDF11, total kidney DNA also increased (GDF11: 2.25 ± 0.131 mg, n = 12 versus control: 1.63 mg ± 0.099, n = 12, P < .001).
Evidence of fibrosis and EMT was also noted. Sirius red, Masson's trichrome staining, and collagen immunohistochemistry revealed revealed significantly increased collagen deposition in the renal cortex of GDF11-treated mice ( Fig. 4 , A , B ) . Quantitative PCR assay results were consistent with histological results, showing that GDF11 treatment increased expression of collagen precursors Coll1 α1, Coll3 α 1, Coll4 α 3 , and the profibrotic TGF-β ( Fig. 4 ,   D ) . Expression of the epithelial marker E-cadherin was reduced ( Figure 4 D ) , while staining for vimentin, a mesenchymal marker, 46 appeared in the tubular epithelium of GDF11-treated kidneys but not controls ( Fig. 4 , C ) .
GDF11-induces kidney injury associated with activation of pSMAD2 and was blocked by follistatin
Genetic and biochemical data indicate that GDF11 binds and activates a TGFBR1/ALK5 and ACVR2b complex that typically signals through phosphorylation of SMAD2/3 and association with SMAD4. 61 Consistent with GDF11 activation of these pathways in renal cells, GDF11 treatment induced SMAD2 phosphorylation in mouse kidneys. Western blot analysis revealed increased phosphorylation of SMAD2 with GDF11 treatment, evident as early as 3 days postinjection and in all GDF11-treated kidney samples ( Fig. 5 , A ) . Immunohistochemistry revealed increased overall pS-MAD2 staining, as well as an increased fraction of positive-staining tubular epithelial cells (but not glomerular cells) in GDF11-treated kidneys ( Fig. 5 , B ) . This distribution is consistent with the known expression pattern of TGFBR1/ALK5 and ACTRIIB/ACVR2B in tubular cells. 14 We then examined the ability of follistatin, an inhibitor of both myostatin and GDF11-receptor binding, 14,15 , 54,62 to block CHO-GDF11-induced kidney failure. We injected control or follistatin-expressing cells into a contralateral leg from the GDF11-secreting cells. Such dual administration of CHO-GDF11/ CHOfollistatin cells doubled survival time (to moribund) as compared with CHO-GDF11/CHO-controls ( Fig. 5 , C ) . These results suggest that GDF11 acts by receptor binding and direct activation of the SMAD2/3 pathway in the kidney and not indirectly because of effects on other tissues. * P < .05 , * * P < .01, * * * P < .001.
Reduced GDF11 expression leads to reduced fibrosis after UUO
Gdf11 expression was increased after fibrotic injury induced by unilateral ureteric obstruction ( Fig. 1 , E ) . We tested whether reduced GDF11 expression would lessen kidney fibrosis. Gdf11 + / − mice were grossly normal and fertile with apparently normal life spans. At 8 weeks of age, baseline expression of Gdf11 in Gdf11 + /-mouse kidneys was ∼36% of normal (0.363 ± 0.0155 [ n = 5]; P < .001; Fig. 6 , C ) . Sirius red staining of Gdf11 + /-mouse kidneys was significantly reduced relative to wild-type littermates, suggesting reduced collagen ( Fig. 6 , A , B ) . Furthermore, expression by PCR of Col1a1 and Col3a1 were 57% and 25% lower, respectively, in nonobstructed Gdf11 + / − kidneys ( Fig. 6 , C ) . GDF11 + /-mice were then subjected to UUO. At 14 days, Gdf11 expression was increased nearly 8-fold in the contralateral (uninjured) kidneys of Gdf11 + /-mice and nearly 5-fold in wild-type mice ( Fig. 6 , F ) consistent with the gene being highly induced after renal injury . Further studies * P < .05 , * * P < .01, * * * P < .001.
will be required to understand the mechanism of the increased induction in the heterozygous mice. In contrast, Gdf11 expression in the injured/obstructed Gdf11 + / − kidneys remained elevated at ∼2.5-fold over nonoperated levels. Staining for both Sirius red and Masson's trichrome were reduced in the obstructed kidneys of Gdf11 + / − versus wild-type mice ( Fig. 6 , D , E ) . Morever, expression of Col1a1 , Col3a1 , and Tgfb were reduced in the ligated kidneys of Gdf11 + / − mice versus wild-types, while expression of Acta2 and Fsp1 were unchanged ( Fig. 6 , G ) . Thus, decreased Gdf11 expression is associated with reduced fibrosis after injury.
GDF-11 activates fibroblasts in vitro
Renal fibrosis is mediated in part by activation of interstitial fibroblasts to myofibroblasts and EMT of tubular epithelial cells. [63] [64] [65] Thus, we sought to determine the effects of recombinant GDF11 on the well-characterized renal fibroblast cell line NRK49f. 66 GDF11 treatment promoted a dose-dependent proliferation of NRK49f cells, although GDF11 was roughly 5-75-fold less potent than TGF-β ( Fig. 7 , A ) . GDF11 also activated the myofibroblastic phenotype, as shown by induction of collagen and αSMA ( Fig. 7 , B ) .
NRK49f cells treated with GDF11 changed from a flat, hexagonal morphology and toward a more three-dimensional, spindle-shaped morphology with the formation of actin stress fibers ( Fig. 7 , C ) .
GDF11-mediated EMT of renal tubular epithelial cells in vitro
The acquisition of mesenchymal markers (vimentin, αSMA) in tubular epithelial cells and the reduction of renal E-cadherin expression observed with excess GDF11 in vivo indicated that GDF11 might induce EMT. We treated several renal epithelial cell lines with GDF11, including the human proximal tubular cell line HK-2, 67 the normal rat kidney epithelial cell line NRK52e, 68 and the murine intramedullary-collecting duct cell line IMCD-3. 69 Recombinant GDF11 exposure induced a morphologic change in each of these cell lines, away from the typical close-contact, cobblestone appearance of epithelial cells and toward an elongated, spindleshaped, and scattered appearance typical of myofibroblast cells. In this trial, CHO-GDF11 mice were euthanized when they became moribund 9 days after injection. CHO-control/CHO-follistatin-treated mice were because of tumor burden at 18 days. Mice bearing both CHO-follistatin/CHO-GDF11 cells survived to 18 days and were killed. P < .0 0 01. IMCD-3 murine cells were chosen for further analysis ( Fig. 8 , A ) . Although GDF11 treatment did not affect prolif eration of IMCD-3 cells, it induced stress-fiber formation and expression of fibrotic genes and mesenchymal markers. GDF11 induced expression of Col1a1 , Acta2 , and Vim but reduced expression of the epithelial marker E-cadherin, Cadh1 ( Fig. 8 , B ) . Evidence of an EMT was also observed in cells grown to confluence on chamber slides. Carriertreated cells stained strongly for E-cadherin, which was localized in thick bands corresponding to cell-cell boundaries, while GDF11-treated cells showed markedly reduced or absent E-cadherin staining ( Fig. 8 , C ) . Moreover, αSMA and vimentin were observed at low levels in punctate granules scattered throughout the cytoplasm in carrier-treated cells, but expression of both was strongly induced in the cytoplasm of GDF11-treated IMCD-3 cells ( Fig. 8 , C ) . GDF11 also increased expression of the EMT mediator Snail1 , 70 reduced expression of the epithelial-promoting factor Bmp7 , 71 but did not affect Tgfb expression ( Fig. 8 , D ) .
To determine whether the observed in vitro effects of GDF11 might be mediated by contaminating TGF β, we pretreated IMCD-3 cells with the GDF11 binding protein follistatin, which has no known activity for TGF-β. Follisatin inhibited GDF11-induced upregulation of αSma and Vim expression ( Fig. 8 , E) . Treatment with SB43154, 72 an inhibitor of the receptor shared by GDF11
and TGF-β, TGF βR1/ALK5, preserved the cobblestone morphology of IMCD-3 cells and reduced the expression of αSma and Vim both at baseline and in response to GDF11 ( Fig. 8 , F , G ) . GDF11 treatment caused intracellular redistribution of SMAD2. SMAD2 was roughly distributed throughout the cytoplasm and nucleus in most untreated IMCD-3 cells. GDF11 induced SMAD2 nuclear concentration within 30 minutes after treatment ( Fig. 8 ,  H ) . Furthermore, addition of the SMAD3 inhibitor SIS3 73 significantly reduced GDF11-mediated induction of αSma and Vim ( Fig. 8 , I ) .
Discussion
We have shown that GDF11 is a critical regulator of adult mouse kidney fibrosis and tubular function. Gdf11 was expressed in the adult mouse kidney and upregulated after kidney injury. Furthermore, excess GDF11 induced kidney atrophy, fibrosis, and failure. These renal effects of GDF11 were associated with pSMAD2 and ameliorated by coadministration of the GDF11-binding protein follistatin. We also show that GDF11 expression strongly correlated with increased fibrosis; Gdf11 + / − mice, haploinsufficient for GDF11, had reduced baseline collagen expression and less fibrotic injury after UUO. Exogenous GDF11 also induced proliferation and activation of renal fibroblasts and EMT in tubular epithelial cell cultures. These results indicate that GDF11 is increased in response to renal injury and contributes to the fibrosis that leads to progressive kidney disease.
Renal tubular epithelial cells that survive injury or insult respond by dedifferentiating, losing polarity and epithelial cell markers, and often delaminating from neighboring cells. This process facilitates at least 2 outcomes: (1) proliferation and epithelial redifferentiation to heal the wounded tubular epithelium and restore function and (2) EMT to form interstitial myofibroblasts that then secrete extracellular matrix and contribute to scar formation. However, this repair pathway might induce pathology when signals promoting EMT persist, reducing epithelial function and increasing matrix synthesis and deposition by tubular cells. Loss of renal function, particularly urine-concentrating ability, is tightly coupled with interstitial fibrosis in human disease and experimental models. 74 Ureteric obstruction, for example, results in long-term urine-concentrating defects, loss of aquaporin expression, and robust fibrosis. [75] [76] [77] Clinically, fibrosis is believed to be the cause of the high risk of chronic kidney disease in patients who had a previous episode of acute kidney injury. [78] [79] [80] * P < .05, * * P < .01, * * * P < .001. and treated for 48 hours with carrier containing no growth factor or with 50 ng/mL GDF11. * * P < .01, * * * P < .001.
Exogenous GDF11 induces expression of mesenchymal markers on tubular epithelial cells in vivo and in vitro and stimulates tubular epithelial cell proliferation in vivo, suggesting that GDF11 may mediate dedifferentiation and proliferation of tubules in pathologic conditions. Epithelial phenotype loss may promote proliferation but also leads to dysfunction, including urine-concentrating defects through loss of differentiated states and loss of cell polarity. Alternatively and additionally, GDF11-activated SMAD proteins may mediate these effects through transcriptional regulation. GDF11 induces Snail, a zinc-finger transcription factor that represses * P < .05, * * P < .01, * * * P < .001.
E-cadherin expression. The combined effects of gene repression and dedifferentiation, ultimately, might be responsible for loss of urine-concentrating function. In development and adulthood, the differentiated phenotype of tubular epithelial cells is likely mediated by a balance of factors, several of which are TGF-β family members. BMP-7 is an endogenous renal factor required for kidney organogenesis that inhibits TGF-β-mediated EMT, promotes mesenchymal-to-epithelial transition in vivo and in vitro, and is nephroprotective in models of fibrotic kidney injury. 71 We show that GDF11, which is also required for kidney organogenesis, 20 is a potent mediator of EMT in vivo and in vitro. The balance of GDF11 and BMP-7 signaling in tubular epithelial cells may determine, in part, differentiated cellular phenotype. Altered GDF11 activity also resulted in dysregulated expression of proteins involved in activating (BMP-1) or inhibiting (follistatin, BMP-7) GDF11 and related family members, indicating a complex regulatory network underlying these interrelated genes.
In summary, our results provide a potential new mediator of renal fibrosis and loss of function in renal injury. Inhibition of GDF11 activation, binding, and signaling presents a novel therapeutic target that might slow fibrosis and retard loss of function in chronic kidney disease.
